265 - Antimicrobial Stewardship Across the Globe

Saturday, October 22, 2022

3:15 PM – 4:30 PM US ET

Location: 202 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Twisha Patel, PharmD, BCIDP

Subject Matter Expert / Infectious Diseases Pharmacist, International Infection Control Program
Chenega Enterprise Systems and Solutions (CHESS) / Centers for Disease Control and Prevention
Ann Arbor, MI, United States

Disclosure(s): No financial relationships to disclose
Payal Patel, MD, MPH

Dr.
Intermountain Healthcare
Ann Arbor, MI, United States

Disclosure(s): Qiagen: Honoraria (Terminated)

Faculty(s)

Khalid Eljaaly, PharmD, MS, BCPS, BCIDP, FCCP

Associate Professor and Infectious Disease Pharmacy Consultant
King Abdulaziz University, Saudi Arabia
Jeddah, Saudi Arabia

Disclosure(s): No financial relationships to disclose

Slides
Icaro Boszczowski, MD

Hospital Epidemiologist
Infection Control Department
Hospital Alemão Oswaldo Cruz
São Paulo, Sao Paulo, Brazil

Disclosure(s): No financial relationships to disclose

Slides
Hitoshi Honda, MD

Clinical Professor
Division of Infectious Diseases
Fujita Health University School of Medicine
Toyoake, Aichi, Japan

Disclosure(s): Moderna, Inc.: Honoraria (Ongoing)

Slides

Disclosure(s):

Twisha S. Patel, PharmD, BCIDP: No financial relationships to disclose

Payal K. Patel, MD, MPH: Qiagen: Honoraria (Terminated)

Khalid Eljaaly, PharmD, MS, BCPS, BCIDP, FCCP: No financial relationships to disclose

Icaro Boszczowski, MD: No financial relationships to disclose

Hitoshi Honda, MD: Moderna, Inc.: Honoraria (Ongoing)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

review the impact of national policy on antimicrobial stewardship at healthcare facilities in Japan
identify successes and failures for implementing safeguards to protect the use of antibiotics;
review the patterns of antimicrobial use and antimicrobial resistance in the context of the COVID-19 pandemic, especially in LMICs

Presentations:

3:15 PM – 3:40 PM US ET

Impact of National Policy on Antimicrobial Stewardship in Japan
Speaker: Hitoshi Honda, MD – Fujita Health University School of Medicine
3:40 PM – 4:05 PM US ET

Introducing Safeguards to Protect the Use of Antibiotics
Speaker: Khalid Eljaaly, PharmD, MS, BCPS, BCIDP, FCCP – King Abdulaziz University, Saudi Arabia
4:05 PM – 4:30 PM US ET

Reviewing Antibiotic Use and Antimicrobial Resistance in LMICs: Impact of COVID-19 Pandemic
Speaker: Icaro Boszczowski, MD – Hospital Alemão Oswaldo Cruz